You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
1 October 2024
Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed
23 September 2024
Pentixapharm Holding AG Sets Price Range for Planned IPO
12 September 2024
Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange
26 August 2024
Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency
3 July 2024
Pentixapharm Acquires Target Discovery Business of Glycotope
1 July 2024
Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler